Cargando…

Radical prostatectomy for high-risk prostate cancer | Opinion: NO

Detalles Bibliográficos
Autores principales:	Ghodoussipour, Saum, Cacciamani, Giovanni Enrico, Abreu, Andre Luis de Castro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2019
Materias:	Difference of Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786100/ https://www.ncbi.nlm.nih.gov/pubmed/31149790 http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.03.03

Ejemplares similares

Super active surveillance for low-risk prostate cancer | Opinion: No
por: Ghodoussipour, Saum, et al.
Publicado: (2019)

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
por: Reis, Leonardo O., et al.
Publicado: (2019)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No
por: Ristau, Benjamin T., et al.
Publicado: (2016)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes
por: da Costa, Walter Henriques, et al.
Publicado: (2016)

PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation? Opinion: No
por: Clavell-Hernández, Jonathan, et al.
Publicado: (2017)

PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation? Opinion: Yes
por: Alzweri, Laith M., et al.
Publicado: (2017)

Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: YES
por: Torres, Luiz Otavio
Publicado: (2018)

Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: Not Yet
por: Wroclawski, Marcelo Langer, et al.
Publicado: (2018)

Super active surveillance for low-risk prostate cancer | Opinion: Yes
por: Reis, Leonardo O., et al.
Publicado: (2019)

Focal therapy will be the next step on prostate cancer management? | Opinion: Yes
por: Zequi, Stênio de Cássio
Publicado: (2017)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: No
por: Mitin, Timur
Publicado: (2017)

Focal therapy will be the next step on prostate cancer management? | Opinion: No
por: Matheus, Wagner Eduardo, et al.
Publicado: (2017)

Most of patients with localized prostate cancer will be treated in the future? | Opinion: No
por: Schulman, Ariel A., et al.
Publicado: (2017)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: Yes
por: Monteiro, Leonardo L., et al.
Publicado: (2017)

MRI should be routine for all patients with localized prostate cancer? | Opinion: No
por: Nelson, Joel B.
Publicado: (2016)

Most of patients with localized prostate cancer will be treated in the future? | Opinion: Yes
por: Dell’Oglio, Paolo, et al.
Publicado: (2017)

Opinion: Endoscopic Urethrotomy
por: Cavalcanti, André G., et al.
Publicado: (2015)

MRI should be routine for all patients with localized prostate cancer? | Opinion: Yes
por: Baroni, Ronaldo Hueb
Publicado: (2016)

Opinion: No
por: Chiles, Kelly A., et al.
Publicado: (2015)

Opinion: No
por: Ackerman, A. Lenore, et al.
Publicado: (2016)

Social Media in the Urology Practice | Opinion: NO
por: Silva, Rodrigo Donalisio Da, et al.
Publicado: (2019)

Opinion: Yes
por: Vieira, Marcelo
Publicado: (2015)

Opinion: Yes
por: Althof, Stanley E.
Publicado: (2015)

Opinion: Treat
por: Mazzuchi, Eduardo
Publicado: (2016)

Opinion: Yes
por: Cintra, Caio Cesar, et al.
Publicado: (2016)

Opinion: Substitution Urethroplasty
por: Santucci, Richard A.
Publicado: (2015)

Opinion: Anastomotic Urethroplasty
por: Siegel, Jordan A., et al.
Publicado: (2015)

Opinion: Do not treat
por: Ludwig, Wesley W., et al.
Publicado: (2016)

The Role of Salvage Radical Prostatectomy in Patients with Radiation-Resistant Prostate Cancer
por: Drobner, Jake, et al.
Publicado: (2023)

BPH treatment: laser for everyone | Opinion: NO
por: Almeida, Fernando G., et al.
Publicado: (2018)

HPV vaccination is fundamental for reducing or erradicate penile cancer | Opinion: NO
por: Ornellas, Paulo, et al.
Publicado: (2018)

Opinion: Why I prefer the infrapubic access
por: Bertero, Eduardo B.
Publicado: (2015)

Opinion: Why I prefer the penoscrotal access
por: Gromatzky, Celso
Publicado: (2015)

BPH treatment: laser for everyone | Opinion: YES
por: Sacomani, Carlos A. R., et al.
Publicado: (2018)

Social Media in the Urology Practice | Opinion: YES
por: Bellote, Mateus Cosentino, et al.
Publicado: (2019)

HPV vaccination is fundamental for reducing or erradicate penile cancer | Opinion: YES
por: Voris, Brunno Raphael Iamashita, et al.
Publicado: (2018)

Should routine neonatal circumcision be a policy to prevent penile cancer? | Opinion: No
por: Tang, Dominic H., et al.
Publicado: (2017)

Should routine neonatal circumcision be a police to prevent penile cancer? | Opinion: Yes
por: Ornellas, Antonio Augusto, et al.
Publicado: (2017)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Henk, G. van der Poel, et al.
Publicado: (2016)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Krishnananthan, Nishanth, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_auten8sh8vln1f7t9352p5e9qm